Save your place

Sign in to WhoBought

Please try again later.

Esperion Therapeutics, Inc. (ESPR) institutional ownership

Latest close $3.18 Jul 14, 2026
Market cap$277M 52-week range $3.18 - $3.18 SectorHealthcare
Funds holding · Q1 2026
187
reported ESPR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
97 buyers · 90 sellers

Esperion Therapeutics, Inc. (ESPR) price and institutional activity

Dates

Q1 2026

$0 bought by 97 investors
Wasatch Advisors LPTwo Sigma Investments, LP +95 more
$0 sold by 90 investors
Two Sigma Advisers, LPMillennium Management LLC +88 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Esperion Therapeutics, Inc. (ESPR) institutional activity · 187

Investor Type Est. change Change Δ Own Date
Wasatch Advisors LP · Added
Change +6.3M Date Q1 2026
Wasatch Advisors LP Added· Q1 2026 +6.3M Q1 2026
Two Sigma Investments, LP · Added
Change +4.7M Δ Own +99.5% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +4.7M +99.5% Q1 2026
Orbimed Advisors LLC · Added
Change +4.6M Date Q1 2026
Orbimed Advisors LLC Added· Q1 2026 +4.6M Q1 2026
UBS Group AG · Added
Change +4.0M Date Q1 2026
UBS Group AG Added· Q1 2026 +4.0M Q1 2026
Armistice Capital, LLC · New
Change +3.9M Date Q1 2026
Armistice Capital, LLC New· Q1 2026 +3.9M Q1 2026
Two Sigma Advisers, LP · Exited
Change −3.5M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −3.5M −100.0% Q1 2026
Millennium Management LLC · Reduced
Change −3.3M Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −3.3M Q1 2026
Privium Fund Management B.V. · New
Change +3.3M Date Q1 2026
Privium Fund Management B.V. New· Q1 2026 +3.3M Q1 2026
Eversept Partners, LP · Reduced
Change −2.1M Date Q1 2026
Eversept Partners, LP Reduced· Q1 2026 −2.1M Q1 2026
Point72 Asset Management, L.P. · New
Change +1.7M Date Q1 2026
Point72 Asset Management, L.P. New· Q1 2026 +1.7M Q1 2026
Marshall Wace, LLP · Added
Change +1.6M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +1.6M Q1 2026
Walleye Capital LLC · Reduced
Change −1.6M Date Q1 2026
Walleye Capital LLC Reduced· Q1 2026 −1.6M Q1 2026
State Street · Added
Change +1.1M Date Q1 2026
State Street Added· Q1 2026 +1.1M Q1 2026
Rhenman & Partners Asset Management AB · New
Change +985K Date Q1 2026
Rhenman & Partners Asset Management AB New· Q1 2026 +985K Q1 2026
Royce & Associates LP · Reduced
Change −975K Date Q1 2026
Royce & Associates LP Reduced· Q1 2026 −975K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 187

Famous investor activity in Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics, Inc. (ESPR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Hoffman Robert E. · Director 3 operations -132K
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Hoffman Robert E. Director 3 operations -132K 0 Jul 13, 2026 Jul 13, 2026
Carroll J. Martin · Director 4 operations -275K
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Carroll J. Martin Director 4 operations -275K 0 Jul 13, 2026 Jul 13, 2026
Shepard Jay · Director 4 operations -262K
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Shepard Jay Director 4 operations -262K 0 Jul 13, 2026 Jul 13, 2026
Fischer Seth H. Z. · Director 4 operations -239K
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Fischer Seth H. Z. Director 4 operations -239K 0 Jul 13, 2026 Jul 13, 2026
Thompson John Craig · Director 2 operations -120K
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Thompson John Craig Director 2 operations -120K 0 Jul 13, 2026 Jul 13, 2026
Harlow John B. Jr · Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -425K
Owned 0 ΔOwn −100.0% Trade date Jul 13, 2026 Filed date Jul 13, 2026
Harlow John B. Jr Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -425K 0 −100.0% Jul 13, 2026 Jul 13, 2026
Looker Benjamin · Officer 4 operations -1.3M
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Looker Benjamin Officer 4 operations -1.3M 0 Jul 13, 2026 Jul 13, 2026
Halladay Benjamin · Officer 4 operations -1.3M
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Halladay Benjamin Officer 4 operations -1.3M 0 Jul 13, 2026 Jul 13, 2026
Koenig Sheldon L. · Director 4 operations -4.2M
Owned 0 Trade date Jul 13, 2026 Filed date Jul 13, 2026
Koenig Sheldon L. Director 4 operations -4.2M 0 Jul 13, 2026 Jul 13, 2026
Looker Benjamin · Officer Sell −$37K
Price $3.16 Qty −12K Owned 668K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Looker Benjamin Officer Sell $3.16 −12K −$37K 668K Jun 17, 2026 Jun 18, 2026
Koenig Sheldon L. · Director Sell −$169K
Price $3.15 Qty −54K Owned 2.1M Trade date Jun 17, 2026 Filed date Jun 18, 2026
Koenig Sheldon L. Director Sell $3.15 −54K −$169K 2.1M Jun 17, 2026 Jun 18, 2026
Halladay Benjamin · CFO Sell −$34K
Price $3.15 Qty −11K Owned 703K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Halladay Benjamin CFO Sell $3.15 −11K −$34K 703K Jun 17, 2026 Jun 18, 2026
Thompson John Craig · Director Grant (A) 80K
Owned 80K Trade date May 28, 2026 Filed date Jun 1, 2026
Thompson John Craig Director Grant (A) 80K 80K May 28, 2026 Jun 1, 2026
Shepard Jay · Director Grant (A) 80K
Owned 164K Trade date May 28, 2026 Filed date Jun 1, 2026
Shepard Jay Director Grant (A) 80K 164K May 28, 2026 Jun 1, 2026
Hoffman Robert E. · Director Grant (A) 80K
Owned 85K Trade date May 28, 2026 Filed date Jun 1, 2026
Hoffman Robert E. Director Grant (A) 80K 85K May 28, 2026 Jun 1, 2026
15 of 32
15 of 32 Sign in to continue to older insider transactions.

Esperion Therapeutics, Inc. (ESPR) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Deep Track Capital, LP
% of shares outstanding 10.0% Filing date Dec 9, 2021
Deep Track Capital, LP 10.0% Dec 9, 2021
Glazer Capital, LLC 21.0M
% of shares outstanding 8.2% Filing date Jun 8, 2026
Glazer Capital, LLC 21.0M 8.2% Jun 8, 2026
Blackrock, Inc. 14.3M
% of shares outstanding 7.3% Filing date Nov 8, 2024
Blackrock, Inc. 14.3M 7.3% Nov 8, 2024
Cvi Investments, Inc. 5.5M
% of shares outstanding 6.9% Filing date Feb 14, 2023
Cvi Investments, Inc. 5.5M 6.9% Feb 14, 2023
Meditor Group Ltd 4.5M
% of shares outstanding 6.1% Filing date Jan 4, 2023
Meditor Group Ltd 4.5M 6.1% Jan 4, 2023
Flynn James E 5.0M
% of shares outstanding 5.0% Filing date May 17, 2022
Flynn James E 5.0M 5.0% May 17, 2022
Sabby Management, LLC 3.1M
% of shares outstanding 5.0% Filing date Jan 5, 2022
Sabby Management, LLC 3.1M 5.0% Jan 5, 2022
BlackRock Inc. 4.6M
% of shares outstanding 4.9% Filing date Jun 8, 2023
BlackRock Inc. 4.6M 4.9% Jun 8, 2023
8 of 15

Esperion Therapeutics, Inc. (ESPR) ownership FAQ

Who owns ESPR?

187 reporting institutions disclosed ESPR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.